New blood test could spot colon cancer before it spreads

NCT ID NCT06342440

First seen Jun 18, 2026 · Last updated Jun 22, 2026 · Updated 1 time

Summary

This study is testing a new blood test called DENEB that looks for tiny genetic markers (microRNAs) to detect colorectal cancer and precancerous polyps early. Researchers will collect blood samples from 2,000 people who are also getting a colonoscopy, then compare the test's accuracy. The goal is to create a simple, non-invasive screening option that could catch the disease sooner.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Barcelona University

    RECRUITING

    Barcelona, Spain

    Contact

    Contact Email: •••••@•••••

    Contact

    Contact

    Contact

  • City of Hope Medical Center

    RECRUITING

    Monrovia, California, 91016, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

  • IRCCS San Raffaele

    RECRUITING

    Milan, Italy

    Contact

    Contact

    Contact Email: •••••@•••••

  • Mie University

    RECRUITING

    Mie, Japan

    Contact

    Contact

    Contact

    Contact

  • The First Affiliated Hospital of Dalian Medical University

    RECRUITING

    Dalian, China

    Contact

    Contact

    Contact

  • University of California San Diego

    RECRUITING

    San Diego, California, 92093, United States

    Contact

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

DENEB blood test (measures microRNA levels in blood)

What this could lead to

If successful, this blood test could offer a simple, non-invasive way to catch colorectal cancer and precancerous growths early, potentially saving lives through earlier treatment.

What could go wrong

This is an early-stage study (2000 participants) focused on measuring accuracy. The test may not be sensitive or specific enough to replace colonoscopy, and results may not apply to everyone.

Conditions

The condition(s) this trial relates to.

adenomatous colon polyp colon dysplasia colonic neoplasm colorectal adenocarcinoma colorectal adenoma colorectal cancer colorectal neoplasm colorectal serrated adenocarcinoma hereditary mixed polyposis syndrome polyp of large intestine polyposis syndrome, hereditary mixed, 1

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.